Nation’s Third-Largest Health Insurer Restricts Power Morcellator Coverage
Aetna, Inc. announced yesterday that it will no longer routinely cover hysterectomies and myomectomies that involve the use of a power morcellator. With more than 23 million members, Aetna is the nation’s third-largest insurer, according to a report published by … Continue reading
Boston Scientific to Settle Nearly 3,000 Transvaginal Mesh Claims
Boston Scientific Corp. disclosed yesterday that it had reached an agreement to settle nearly 3,000 transvaginal mesh lawsuits for a total of $119 million. Court documents indicate that the settlement is the first agreed to by the company, which is … Continue reading
Zofran Birth Defects Litigation Continues to Grow
The litigation involving Zofran and birth defects continues to grow, as two more filings were submitted on April 17th in Texas and Massachusetts. According to court documents, both complaints accuse GlaxoSmithKline of concealing data that linked the anti-nausea drug to … Continue reading
Power Morcellators: Is the FDA’s 510(K) Program to Blame?
An insurance industry trade group has implied that the U.S. Food & Drug Administration (FDA) 510(k) clearance program may be partly to blame for the safety crisis involving power morcellators. America’s Health Insurance Plans (AHIP) is now asking Congress to … Continue reading
Generic Drug Regulations Have Industry, Consumer Groups at Odds
Consumer advocates and the pharmaceutical industry are engaged in a battle over the U.S. Food & Drug Administration’s (FDA) regulation of generic drug labels. The outcome of this fight has the potential to impact consumers everywhere, who are currently denied … Continue reading
Zofran Blamed for Cleft Palate in New Montana Lawsuit
Zofran, an anti-nausea drug often used off-label to alleviate nausea and vomiting related to pregnancy, is the subject of yet another product liability claim over its alleged association with birth defects. This newest Zofran lawsuit claims that GlaxoSmithKline failed to … Continue reading
Newly Filed Testosterone Case Blames Axiron for Fatal Cardiac Arrest
An Oklahoma woman has filed a testosterone treatment lawsuit against Eli Lilly & Co., claiming that Axiron was to blame for her husband’s death from cardiac arrest. Like similar cases filed over the past year, the lawsuit accuses Eli Lilly … Continue reading
Power Morcellators Increasingly Sidelined, as More Insurers Consider Coverage Limitations
Hysterectomies and fibroid removal surgeries that involve the use of a power morcellator have been on the decline since U.S. health regulators first warned that the surgical tools might cause the spread of undiagnosed uterine cancers. But now a new … Continue reading
Researchers Accuse Testosterone Treatment Manufacturers of “Disease Mongering”
A pair of medical researchers has accused the manufacturers of AndroGel and other prescription testosterone treatments of engaging in “disease mongering” to drive sales of the medications. The charges, which were made in an editorial that appeared this month in … Continue reading
California Mom Claims Baby a Victim of Zofran Heart Defect
A mother in California has filed a Zofran lawsuit alleging her child is the victim of a heart defect brought on by the anti-nausea medication, which she was prescribed during her first trimester of pregnancy. According to a complaint filed … Continue reading
Follow Us
